As of May 2024 Lyell Immunopharma has a market cap of $0.59 Billion. This makes Lyell Immunopharma the world's 5786th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.59 B | 21.57% |
2023 | $0.48 B | -43.52% |
2022 | $0.86 B | -53.52% |
2021 | $1.86 B |
On Apr 30th, 2024 the market cap of Lyell Immunopharma was reported to be: